$SCYX
SCYNEXIS INC

2018 Q2 Form 10-Q Financial Statement

#000156459018021024 Filed on August 09, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $64.00K $64.00K
YoY Change 0.0% 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.123M $2.361M
YoY Change -10.08% 41.12%
% of Gross Profit
Research & Development $5.599M $4.448M
YoY Change 25.88% -33.2%
% of Gross Profit
Depreciation & Amortization $0.00 $40.00K
YoY Change -100.0% 300.0%
% of Gross Profit
Operating Expenses $7.722M $6.809M
YoY Change 13.41% -18.28%
Operating Profit -$6.745M
YoY Change -18.42%
Interest Expense $397.0K $360.0K
YoY Change 10.28%
% of Operating Profit
Other Income/Expense, Net -$3.099M $2.546M
YoY Change -221.72% 1718.57%
Pretax Income -$10.76M -$4.200M
YoY Change 156.19% -48.34%
Income Tax
% Of Pretax Income
Net Earnings -$10.76M -$4.199M
YoY Change 156.18% -48.34%
Net Earnings / Revenue -16807.81% -6560.94%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.299M -$1.628M
COMMON SHARES
Basic Shares Outstanding 25.80M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.20M $49.30M
YoY Change 11.97% -1.99%
Cash & Equivalents $6.769M $7.450M
Short-Term Investments $48.40M $41.90M
Other Short-Term Assets $1.300M $24.00K
YoY Change 5316.67% -60.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $56.51M $50.85M
YoY Change 11.12% -3.57%
LONG-TERM ASSETS
Property, Plant & Equipment $412.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $573.0K $652.0K
YoY Change -12.12% 53.05%
Total Long-Term Assets $1.593M $981.0K
YoY Change 62.39% 24.81%
TOTAL ASSETS
Total Short-Term Assets $56.51M $50.85M
Total Long-Term Assets $1.593M $981.0K
Total Assets $58.10M $51.84M
YoY Change 12.09% -3.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.600M $1.738M
YoY Change 49.6% 52.99%
Accrued Expenses $1.600M $1.329M
YoY Change 20.39% -54.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.500M $1.349M
YoY Change 307.71%
Total Short-Term Liabilities $13.15M $4.673M
YoY Change 181.49% 3.32%
LONG-TERM LIABILITIES
Long-Term Debt $9.400M $13.10M
YoY Change -28.26%
Other Long-Term Liabilities $9.000M $2.400M
YoY Change 275.0% -52.94%
Total Long-Term Liabilities $18.40M $13.10M
YoY Change 40.43% 156.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.15M $4.673M
Total Long-Term Liabilities $18.40M $13.10M
Total Liabilities $31.50M $20.18M
YoY Change 56.1% 109.13%
SHAREHOLDERS EQUITY
Retained Earnings -$189.3M
YoY Change 14.39%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.55M $31.66M
YoY Change
Total Liabilities & Shareholders Equity $58.10M $51.84M
YoY Change 12.09% -3.16%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$10.76M -$4.199M
YoY Change 156.18% -48.34%
Depreciation, Depletion And Amortization $0.00 $40.00K
YoY Change -100.0% 300.0%
Cash From Operating Activities -$7.900M -$7.380M
YoY Change 7.05% -17.91%
INVESTING ACTIVITIES
Capital Expenditures -$400.0K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$11.93M -$6.970M
YoY Change 71.16% -44.11%
Cash From Investing Activities -$12.33M -$6.970M
YoY Change 76.9% -44.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -230.0K 1.880M
YoY Change -112.23% -91.18%
NET CHANGE
Cash From Operating Activities -7.900M -7.380M
Cash From Investing Activities -12.33M -6.970M
Cash From Financing Activities -230.0K 1.880M
Net Change In Cash -20.46M -12.47M
YoY Change 64.07% 7693.75%
FREE CASH FLOW
Cash From Operating Activities -$7.900M -$7.380M
Capital Expenditures -$400.0K $0.00
Free Cash Flow -$7.500M -$7.380M
YoY Change 1.63% -17.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 us-gaap Deferred Costs
DeferredCosts
230000
CY2017Q4 us-gaap Deferred Costs
DeferredCosts
314000
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
412000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
576000
CY2018Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
328000
CY2017Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0
CY2017Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
32424000
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1313000
CY2018Q2 us-gaap Assets Current
AssetsCurrent
56507000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
44960000
CY2018Q2 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
48425000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6769000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1067000
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
573000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11469000
CY2018Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3220000
CY2017Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
13154000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10144000
CY2018Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
121000
CY2017Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3872000
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10303000
CY2017Q4 us-gaap Liabilities
Liabilities
24440000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2017Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
29000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
226631000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-205250000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
21410000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45850000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28971651
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28971651
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64000
CY2017Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
129000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
129000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5599000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
44622000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16336000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19127000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30192000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5224000
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4448000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10925000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8467000
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2123000
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2361000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4094000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
7722000
us-gaap Operating Income Loss
OperatingIncomeLoss
-14890000
us-gaap Operating Income Loss
OperatingIncomeLoss
-12758000
CY2018Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
99000
CY2017Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
100000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
212000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
200000
CY2018Q2 us-gaap Interest Income Other
InterestIncomeOther
271000
CY2017Q2 us-gaap Interest Income Other
InterestIncomeOther
82000
us-gaap Interest Income Other
InterestIncomeOther
437000
us-gaap Interest Income Other
InterestIncomeOther
150000
CY2018Q2 us-gaap Interest Expense
InterestExpense
397000
CY2017Q2 us-gaap Interest Expense
InterestExpense
360000
us-gaap Interest Expense
InterestExpense
776000
us-gaap Interest Expense
InterestExpense
709000
CY2018Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2874000
CY2017Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2924000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-680000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4447000
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3099000
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2546000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
129000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3688000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-10757000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-4199000
us-gaap Net Income Loss
NetIncomeLoss
-14761000
CY2018Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.23
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.35
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25813675
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40247917
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25590293
us-gaap Profit Loss
ProfitLoss
-14761000
us-gaap Profit Loss
ProfitLoss
-9070000
us-gaap Depreciation
Depreciation
2000
us-gaap Depreciation
Depreciation
39000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
833000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
893000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-411000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-129000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
122000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-165000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
212000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
200000
scyx Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-4000
scyx Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-7000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
200000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
1326000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1328000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-129000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16117000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14153000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
30156000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
25497000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
410000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
46082000
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
2131000
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
168000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
20000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
18000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28081000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5074000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4372000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-28206000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11469000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35656000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7097000
us-gaap Interest Paid Net
InterestPaidNet
901000
us-gaap Interest Paid Net
InterestPaidNet
709000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
359000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
307000
scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
84000
scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
15000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:6pt;margin-top:6pt;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.79%;">Concentration of Credit Risk</p> <p style="margin-bottom:6pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.79%;">Financial instruments, which potentially expose the Company to concentrations of credit risk, consist principally of cash on deposit and cash equivalents held with one bank which exceed FDIC insured limits and certain short-term investments. Ongoing credit evaluations of the customer&#8217;s financial condition are performed and independent credit ratings for the associated counterparties are reviewed by the Company and collateral is not required. The Company's money market fund investment (recognized as cash and cash equivalents) is with what the Company believes to be a high quality issuer. The Company has not experienced any losses in such account.</p></div>
CY2015Q4 scyx Shelf Registration Maximum Equity Offering Price
ShelfRegistrationMaximumEquityOfferingPrice
150000000
CY2018Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2018Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
7300000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4919000
CY2013Q3 us-gaap Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
1500000
CY2018Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2018Q1 us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
The Company has the option to renew for two consecutive five-year periods from the end of the first term. Under the lease, the Company must furnish a security deposit in the form of a standby letter of credit in the amount of $0.3 million, which will be reduced by fifty-five thousand dollars every two years for ten years after the commencement of the lease
CY2013Q3 scyx Deferred Revenue Estimated Performance Period
DeferredRevenueEstimatedPerformancePeriod
P70M
CY2018Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
175000
CY2017Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
251000
CY2017Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
32424000
CY2018Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
48425000
CY2017Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
74000
CY2018Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
8000
CY2017Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
79000
CY2018Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
5000
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
23000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
29000
CY2018Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
260000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
304000
CY2018Q1 scyx Lease Agreement Area Of Office Space
LeaseAgreementAreaOfOfficeSpace
19275
CY2018Q1 us-gaap Security Deposit
SecurityDeposit
300000
CY2018Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
55000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
353000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
498000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
508000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
518000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
529000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
7325000
CY2018Q2 scyx Number Of License Agreements
NumberOfLicenseAgreements
2
CY2018Q2 scyx Additional Milestone Payments Maximum
AdditionalMilestonePaymentsMaximum
2300000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
893000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
20000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
18998000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-7000
CY2018Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
4076415
CY2017Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
3075994
CY2018Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
14033
CY2017Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
14033
CY2018Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
30440936
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8012211
CY2018Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
17751500
CY2018Q2 scyx Fair Value Of Liabilities
FairValueOfLiabilities
12200000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3075994
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1148129
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
147708
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4076415
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1958226
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4076415
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.59
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.75
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.63
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.43
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.27
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.43
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M23D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M28D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y3M10D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y7M28D
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
151000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
12000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
10000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
12000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
468000
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
438000
CY2018Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2017Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2018Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2017Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3872000
scyx Derivative Fair Value Gain Loss From Mark To Market Adjustment
DerivativeFairValueGainLossFromMarkToMarketAdjustment
680000
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
12173000

Files In Submission

Name View Source Status
0001564590-18-021024-index-headers.html Edgar Link pending
0001564590-18-021024-index.html Edgar Link pending
0001564590-18-021024.txt Edgar Link pending
0001564590-18-021024-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gx0adntq0u3i000001.jpg Edgar Link pending
gx0adntq0u3i000002.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scyx-10q_20180630.htm Edgar Link pending
scyx-20180630.xml Edgar Link completed
scyx-20180630.xsd Edgar Link pending
scyx-20180630_cal.xml Edgar Link unprocessable
scyx-20180630_def.xml Edgar Link unprocessable
scyx-20180630_lab.xml Edgar Link unprocessable
scyx-20180630_pre.xml Edgar Link unprocessable
scyx-ex311_8.htm Edgar Link pending
scyx-ex312_7.htm Edgar Link pending
scyx-ex321_6.htm Edgar Link pending
Show.js Edgar Link pending